Ophthalmic Drug Delivery Systems for the Treatment of Retinal Diseases: Basic Research to Clinical Applications

• Type of Material: Article
• Authors: Henry Edelhauser, Emory University; Cheryl L. Rowe-Rendleman, Omar Consulting Group; Michael R. Robinson, Allergan Inc.; Daniel G. Dawson, Emory University; Gerald J. Chader, University of Southern California, Los Angeles; Hans Grossniklaus, Emory University; Kay D. Rittenhouse, Pfizer; Clive G. Wilson, University of Strathclyde; David A. Weber, MacuSight; Baruch D. Kuppermann, University of California-Irvine; Karl G. Csaky, Duke University; Timothy W Olsen, Emory University; Uday B. Kompella, University of Colorado-Denver; V. Michael Holers, Taligen Therapeutics; Gregory S. Hageman, The University of Iowa; Brian C. Gilger, North Carolina State University; Peter A. Campochiaro, Johns Hopkins University; Scott M. Whitcup, Allergan Inc.; Wai T. Wong, National Institutes of Health
• Language: English
• Date: 2010-11
• Publisher: Association for Research in Vision and Ophthalmology, Inc.
• Publication Version: Final Published Version
• Copyright Statement: © Association for Research in Vision and Ophthalmology
• Final Published Version (URL): http://www.iovs.org/content/51/11/5403
• Title of Journal or Parent Work: Investigative Ophthalmology & Visual Science
• Volume: 51
• Issue: 11
• Start Page: 5403
• End Page: 5420
• Grant/Funding Information: Supported by NIH Core Grant 5P30EY006360-23 (HFE, HEG, TWO), NIH Grant SR24 EY017045 (HFE, HEG, UBK), and NIH Grant R24 EY017404 (GSH); the Alcon Research Institute (GSH); and an unrestricted grant from Research to Prevent Blindness (TWO).
• Research Categories: Health Sciences, Opthamology

Abstract

The ARVO 2009 Summer Eye Research Conference (SERC 2009) on Ophthalmic Drug Delivery Systems was held July 31 and August 1, 2009, at the National Institutes of Health (NIH) in Bethesda, Maryland. The conference provided an opportunity to gather a diverse group of more than 200 experts from both academic ophthalmology and the ophthalmic pharmaceutical industry, including laboratory researchers and clinicians, to discuss recent advances in delivery systems that convey ocular drugs to the posterior segment and how these systems might be successfully used in commercial products.